Naturopathic Treatment for the Prevention of Cardiovascular Disease
Phase 3
Completed
- Conditions
- Cardiovascular Disease
- Interventions
- Other: Conventional medical treatment (Atorvastatin,Fluvastatin,Lovastatin,Pravastatin,Rosuvastatin,Simvastatin)
- Registration Number
- NCT00718796
- Lead Sponsor
- The Canadian College of Naturopathic Medicine
- Brief Summary
This study is designed to test the ability of a comprehensive naturopathic approach to reduce important risk factors for the development of cardiovascular disease. Treatment will take place over the course of one year and the comparator/control group will be followed by their medical doctors and be given conventional care.
- Detailed Description
Interventions will consist of an individualized treatment approach guided by an expert panel of clinicians who treat patients with cardiovascular disease. These interventions will consist of a combination of dietary, lifestyle and specific recommendations for supplementation. As this is a pragmatic study, blinding will not be attempted nor is appropriate.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
- 18 to 65 years old
- CUPW worker
- prescreening indicates higher than normal TC/HDL ratio
Exclusion Criteria
- Experienced an MI or stroke within past 6 months
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description 2 Conventional medical treatment (Atorvastatin,Fluvastatin,Lovastatin,Pravastatin,Rosuvastatin,Simvastatin) Current care control provided by participants' medical doctor
- Primary Outcome Measures
Name Time Method Metabolic syndrome 1 year General Cardiovascular Risk Profile: Framingham Heart Study 1 year
- Secondary Outcome Measures
Name Time Method Adverse events 1 year HbA1C 1 year Compliance with naturopathic interventions 1 year Quality of Life (Short-form 36) 1 year
Trial Locations
- Locations (1)
Canadian College of Naturopathic Medicine
🇨🇦Toronto, Ontario, Canada